Testing biologics and intracellular signaling inhibitors on pediatric atopic dermatitis: a stairway to modern therapeutic approaches

Expert Opinion on Investigational Drugs
Andrea ChiricozziGiampiero Girolomoni

Abstract

Atopic dermatitis (AD) is the most common cutaneous inflammatory disease in adults and children. In the last few years, the pathogenesis of AD has been profoundly revised, and this has led to the identification of novel druggable targets and the development of new agents targeting specific molecular pathways. Despite the high prevalence of AD in the pediatric population, the clinical development of new treatments, either topical or systemic, has been focused on the adult population in recent years; only a limited number of these new agents have been tested in pediatric cohorts. In this review, we describe the pathogenic model of pediatric AD which shows similarities and substantial differences when compared to adult AD. The identification of therapeutic targets is highlighted, and novel targeted therapies, both topical and systemic, are discussed. The current therapeutic armamentarium for pediatric AD is very limited, and this represents a critical unmet need. The enhancement of clinical research on pediatric patients is necessary to facilitate an increase in the number of new targeted therapeutic options being available on the market.

References

Jan 1, 1990·Journal of Dermatological Science·J M Hanifin
Jan 1, 1993·Dermatology : International Journal for Clinical and Investigative Dermatology
Jul 1, 1996·The Journal of Investigative Dermatology·J M HanifinE S Weiner
Dec 6, 2003·The Journal of Allergy and Clinical Immunology·Calman PrussinThomas B Casale
Jun 5, 2004·International Archives of Allergy and Immunology·Toshio KatsunumaHirohisa Saito
Jun 12, 2004·The Journal of Investigative Dermatology·Matthias SchmuthKenneth R Feingold
Jul 16, 2005·Journal of the American Academy of Dermatology·Richard A Krathen, Sylvia Hsu
Jun 20, 2006·Journal of the American Academy of Dermatology·Paul G VigoIftikhar Hussain
Jun 30, 2006·Yonsei Medical Journal·Seung Hun LeeSung Ku Ahn
Apr 18, 2007·Nature Reviews. Immunology·Stefan Kraft, Jean-Pierre Kinet
Oct 16, 2007·The Journal of Allergy and Clinical Immunology·Benedetta BelloniMartin Mempel
Dec 17, 2009·The Journal of Allergy and Clinical Immunology·Emma Guttman-YasskyJames G Krueger
Mar 9, 2010·Journal of Dermatological Science·Yoshiki Tokura
Mar 11, 2011·The Journal of Allergy and Clinical Immunology·Mayte Suárez-FariñasEmma Guttman-Yassky
Aug 2, 2012·Nature Reviews. Drug Discovery·Charles A DinarelloJos W M van der Meer
Oct 23, 2012·Clinical and Experimental Dermatology·D H KimS K Mun
Jun 20, 2013·The Journal of Allergy and Clinical Immunology·Mayte Suárez-FariñasEmma Guttman-Yassky
Jul 3, 2013·International Archives of Allergy and Immunology·Shuba Rajashri IyengarKari Christine Nadeau
Oct 16, 2013·Journal of the American Academy of Dermatology·Jonathan Lacombe BarriosAnne Des Roches
Feb 1, 2014·The Journal of Investigative Dermatology·Saeko NakajimaKenji Kabashima
Jan 9, 2015·The Journal of Allergy and Clinical Immunology·Hitokazu EsakiEmma Guttman-Yassky
Apr 5, 2015·The Journal of Allergy and Clinical Immunology·Mayte Suárez-FariñasEmma Guttman-Yassky
Jun 11, 2015·Acta Dermato-venereologica·Alexander ZinkMarkus Ollert
Sep 18, 2015·Lancet·Stephan Weidinger, Natalija Novak
Oct 3, 2015·The Journal of Allergy and Clinical Immunology·Shinji NodaEmma Guttman-Yassky
Dec 22, 2015·Journal of the American Academy of Dermatology·Masaki FutamuraEric L Simpson
Aug 9, 2016·The Journal of Allergy and Clinical Immunology·Thomas WerfelCezmi A Akdis
Sep 28, 2016·The Journal of Allergy and Clinical Immunology·Hitokazu EsakiEmma Guttman-Yassky
Dec 15, 2016·The Journal of Allergy and Clinical Immunology·Tali CzarnowickiAmy S Paller
Feb 13, 2017·The Journal of Investigative Dermatology·Elaine C SiegfriedAmy S Paller
Mar 3, 2017·The Journal of Investigative Dermatology·Sally R WilkesHywel C Williams
Apr 10, 2017·The Journal of Allergy and Clinical Immunology·Patrick M BrunnerDonald Y M Leung
May 30, 2017·Drug Design, Development and Therapy·Angelo Massimiliano D'ErmeAndrea Chiricozzi
Jun 7, 2017·The Journal of Allergy and Clinical Immunology·Tali CzarnowickiEmma Guttman-Yassky
Jun 10, 2017·The Journal of Investigative Dermatology·Susan H SmithJavier Cote-Sierra
Jun 29, 2017·Immunological Reviews·Atsushi OtsukaKenji Kabashima
Jul 7, 2017·Drugs·Jusleen AhluwaliaLawrence F Eichenfield
Jul 16, 2017·Clinics in Dermatology·Yael Renert-Yuval, Emma Guttman-Yassky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

© 2022 Meta ULC. All rights reserved